Epstein Secrets

dded, "None of those claims are true, and the margin of victory is going to be enormous, with both the popular vote and the Electoral College." In a Washington Post (11/14, 14.2M) op-ed, David Boies, chairman of Boies, Schiller & Flexner, and Theodore B. Olson, a partner at Gibson, Dunn & Crutcher as well as a f

ble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicamer

dded, "None of those claims are true, and the margin of victory is going to be enormous, with both the popular vote and the Electoral College." In a Washington Post (11/14, 14.2M) op-ed, David Boies, chairman of Boies, Schiller & Flexner, and Theodore B. Olson, a partner at Gibson, Dunn & Crutcher as well as a f

ble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicamer

dded, "None of those claims are true, and the margin of victory is going to be enormous, with both the popular vote and the Electoral College." In a Washington Post (11/14, 14.2M) op-ed, David Boies, chairman of Boies, Schiller & Flexner, and Theodore B. Olson, a partner at Gibson, Dunn & Crutcher as well as a f

ble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and CEO Liz Schrayer; 12:00 PM • Bicamer